Search results
Michael Rosenblatt, M.D., is a former chief medical officer at Merck and a board member of several Flagship companies. He has a long and distinguished career in biomedical research, education and innovation, and holds 19 patents and over 180 publications.
- Dr. Michael Rosenblatt Joins Flagship Ventures ... - Flagship Pioneering
Cambridge, Mass., July 13, 2016 (PR Newswire) – Flagship...
- An Audience With Michael Rosenblatt (from… | Flagship Pioneering
The venture capital group Flagship Ventures has now named...
- Dr. Michael Rosenblatt Joins Flagship Ventures ... - Flagship Pioneering
DR. MICHAEL ROSENBLATT. Senior Partner, Flagship Pioneering. Harvard Medical School Board of Fellows. Dr. Rosenblatt’s career has been in academia, the pharmaceutical industry and biotech/venture. He is a physician, scientist, educator and leader in healthcare.
Jul 23, 2024 · Saint-Prex, Switzerland – 23 July 2024 – Ferring Pharmaceuticals announced today that Dr Michael Rosenblatt joins its Board of Directors as Chairman of the Board Research and Development and Production Committee, replacing Jan Lundberg who is stepping down from his role.
Sep 29, 2016 · Michael Rosenblatt, newly appointed Chief Medical Officer of Flagship Ventures and former Chief Medical Officer at Merck & Co., discusses his move from industry to venture capital.
Michael Rosenblatt, MD. Chief Medical Officer of Flagship Pioneering. Dr. Rosenblatt’s career has been in academia, pharma and biotech/venture. He is a physician-scientist, now serving as Chief Medical Officer of Flagship Pioneering in Cambridge, MA, a firm that originates new biotech companies. Previously, he was Merck’s Chief Medical Officer.
Jul 13, 2016 · Cambridge, Mass., July 13, 2016 (PR Newswire) – Flagship Ventures today announced the appointment of industry veteran Michael Rosenblatt, M.D., to the new position of Chief Medical Officer. In this capacity, Dr. Rosenblatt will lead global clinical development and medical affairs for the organization.
Sep 29, 2016 · The venture capital group Flagship Ventures has now named Michael Rosenblatt as Chief Medical Officer to help its portfolio of companies fill that experience gap. Rosenblatt was Chief Medical Officer at Merck & Co. for 7 years prior to this role, and Dean of Tufts University School of Medicine before that.
